Lead Fertility Program

About Notify Therapeutics

Notify Therapeutics is a preclinical-stage biotech targeting a significant unmet need in fertility: women with low ovarian reserve who do not respond to standard hormonal stimulation. The company's novel, non-hormonal therapy acts on the early stages of follicle development and has shown proof-of-concept efficacy in rodent models and ex-vivo patient samples. If successful, this approach could offer a new treatment paradigm for a large patient population currently with limited options, potentially improving IVF outcomes while reducing risks like multiple pregnancies.

Therapeutic Areas